(Q50883380)

24 March 2018

title

Risk factors for rifampin mono-resistant tuberculosis. (English)

1 reference

24 March 2018

0 references

1 reference

11

Onorato IM

1 reference

24 March 2018

Sarah E. Valway

8

object named as

Valway S

1 reference

24 March 2018

author name string

Ridzon R

1

1 reference

24 March 2018

Whitney CG

2

1 reference

24 March 2018

McKenna MT

3

1 reference

24 March 2018

Taylor JP

4

1 reference

24 March 2018

Ashkar SH

5

1 reference

24 March 2018

Nitta AT

6

1 reference

24 March 2018

Harvey SM

7

1 reference

24 March 2018

Woodley C

9

1 reference

24 March 2018

Cooksey R

10

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

24 March 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

24 March 2018

volume

157

1 reference

24 March 2018

issue

6 Pt 1

1 reference

24 March 2018

page(s)

1881-1884

1 reference

24 March 2018

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Nationwide survey of drug-resistant tuberculosis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Molecular mechanisms of drug resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Rifampicin-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.157.6.9712009

10.1164/AJRCCM.157.6.9712009

21 January 2018

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018